Insider Transactions in Q1 2024 at Encompass Health Corp (EHC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2024
|
John Patrick Darby EVP, Gen Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
15,928
+8.5%
|
-
|
|
Feb 28
2024
|
Edmund Fay Sr. Vice Pres. and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
6,900
+3.29%
|
-
|
|
Feb 28
2024
|
Andrew L Price Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,398
+4.65%
|
-
|
|
Feb 28
2024
|
Mark J Tarr President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
89,500
+7.38%
|
-
|
|
Feb 28
2024
|
Elissa Joy Charbonneau Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,090
+14.1%
|
-
|
|
Feb 28
2024
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,068
+10.61%
|
-
|
|
Feb 25
2024
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,895
-0.62%
|
$217,125
$75.25 P/Share
|
|
Feb 25
2024
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,079
-1.04%
|
$80,925
$75.25 P/Share
|
|
Feb 25
2024
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
506
-2.53%
|
$37,950
$75.25 P/Share
|
|
Feb 25
2024
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-0.4%
|
$28,800
$75.25 P/Share
|
|
Feb 25
2024
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
509
-0.73%
|
$38,175
$75.25 P/Share
|
|
Feb 25
2024
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
410
-0.59%
|
$30,750
$75.25 P/Share
|
|
Feb 24
2024
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,256
-0.48%
|
$169,200
$75.25 P/Share
|
|
Feb 24
2024
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
840
-0.8%
|
$63,000
$75.25 P/Share
|
|
Feb 24
2024
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
356
-1.75%
|
$26,700
$75.25 P/Share
|
|
Feb 24
2024
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
299
-0.31%
|
$22,425
$75.25 P/Share
|
|
Feb 24
2024
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
397
-0.57%
|
$29,775
$75.25 P/Share
|
|
Feb 24
2024
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
320
-0.46%
|
$24,000
$75.25 P/Share
|
|
Feb 23
2024
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,487
-0.53%
|
$186,525
$75.25 P/Share
|
|
Feb 23
2024
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
927
-0.87%
|
$69,525
$75.25 P/Share
|
|
Feb 23
2024
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
434
-2.09%
|
$32,550
$75.25 P/Share
|
|
Feb 23
2024
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
374
-0.39%
|
$28,050
$75.25 P/Share
|
|
Feb 23
2024
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
437
-0.62%
|
$32,775
$75.25 P/Share
|
|
Feb 23
2024
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-0.57%
|
$30,000
$75.25 P/Share
|
|
Jan 17
2024
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
465
+4.9%
|
$32,550
$70.48 P/Share
|
|
Jan 17
2024
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
495
+0.3%
|
$34,650
$70.48 P/Share
|
|
Jan 17
2024
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
488
+24.7%
|
$34,160
$70.51 P/Share
|
|
Jan 16
2024
|
Greg D Carmichael Director |
BUY
Small Acquisition
|
Direct |
4
+0.03%
|
$272
$68.64 P/Share
|
|
Jan 16
2024
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.16%
|
-
|
|
Jan 16
2024
|
John Chidsey Director |
BUY
Grant, award, or other acquisition
|
Direct |
199
+0.12%
|
-
|
|
Jan 16
2024
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
3
+0.3%
|
-
|
|
Jan 16
2024
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
91
+0.21%
|
-
|
|
Jan 16
2024
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
91
+0.21%
|
-
|
|
Jan 16
2024
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.21%
|
-
|
|
Jan 16
2024
|
Donald L Correll Director |
BUY
Grant, award, or other acquisition
|
Direct |
208
+0.21%
|
-
|
|
Jan 16
2024
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.18%
|
-
|
|
Jan 16
2024
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.19%
|
-
|
|
Jan 16
2024
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
24
+0.21%
|
-
|
|
Jan 16
2024
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
37
+0.21%
|
-
|
|
Jan 02
2024
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,288
-8.85%
|
$679,008
$66.72 P/Share
|
|
Jan 02
2024
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,281
-9.88%
|
$150,546
$66.72 P/Share
|
|
Jan 02
2024
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,062
-2.85%
|
$136,092
$66.72 P/Share
|
|
Jan 02
2024
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,935
-1.97%
|
$127,710
$66.72 P/Share
|
|
Jan 02
2024
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,920
-6.55%
|
$324,720
$66.72 P/Share
|
|
Jan 02
2024
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,159
-5.06%
|
$1,660,494
$66.72 P/Share
|